Trading restrictions in IB?

Hi, I am currently thinking about what group I would like to join within IB. I'm heavily interested in healthcare, but I also love trading biotech stocks. Is it a dumb move for me to avoid a HC group so that I can continue to trade biotech stocks? I've been doing very well for what it's worth (although probably just got lucky)

2 Comments
 

Based on the most helpful WSO content, navigating personal trading while working in Investment Banking (IB), especially within a specific sector like healthcare (HC), can indeed present some challenges. Here are a few points to consider:

  1. Pre-clearance Procedures: In most IB firms, employees are required to get pre-clearance for their trades to ensure there's no conflict of interest or insider trading. This process can be stringent and might limit your ability to trade biotech stocks freely if you're working in a healthcare group due to closer scrutiny.

  2. Blacklist and Restricted Lists: Firms often have a list of companies that are off-limits for trading by their employees, especially if the firm is involved in confidential deals with those companies. If you're in a healthcare group, it's likely that a significant number of biotech stocks might be on this list, restricting your trading activities in that sector.

  3. Firm Sentiment on Personal Trading: While personal trading policies vary by firm, the sentiment towards active trading by employees can be cautious. Firms prioritize compliance and the avoidance of conflicts of interest or the appearance of insider trading. Being in a sector-focused group like healthcare could increase scrutiny on your trading activities in related stocks.

  4. Consider Your Long-term Career Goals: If your passion lies in healthcare investment banking, it might be worth considering the potential trade-offs. The experience and network you build within the HC group could significantly benefit your career in the long run, potentially outweighing the benefits of personal trading in the short term.

  5. Alternative Investment Strategies: Some IB professionals choose to invest in diversified ETFs or mutual funds to avoid direct conflicts with their work. This could be a way to remain invested in the market, including biotech, without the same level of scrutiny as individual stock trading.

In summary, while it's not necessarily a "dumb move" to avoid a healthcare group for the sake of continuing to trade biotech stocks, it's important to weigh the potential restrictions and career implications carefully. Consider your long-term career aspirations in IB against your interest in personal trading to make an informed decision.

Sources: Personal Account Trading Restrictions at MBB, Personal Trading Restrictions, https://www.wallstreetoasis.com/forum/investment-banking/new-h1-b-visa-restrictions?customgpt=1

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

Nihil aliquam labore ipsa earum dolor aut blanditiis. Quod praesentium quasi voluptas nobis. Corrupti velit eos ratione provident vel. Earum nemo accusantium qui asperiores non voluptatem nihil aut.

Quia dolorem porro optio odio magnam. Dolor eveniet odio dolores rem quisquam autem sed. Molestiae dolorem quia quod aut ipsam magni. Saepe iusto sapiente eos reiciendis. Aut rerum officia accusantium quam.

Inventore aliquam repellendus architecto sapiente. Commodi beatae enim est rerum veniam rerum quaerat. Non dolorem beatae tenetur magnam est consequatur ut voluptatem. Molestias quos nesciunt voluptatum facilis dolores tempore libero. Vitae quibusdam aut non explicabo pariatur voluptatibus voluptatem. Dignissimos fuga eum esse quas exercitationem eligendi mollitia. Sint placeat optio id et natus ea cumque.

I'm an AI bot trained on the most helpful WSO content across 17+ years.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.2%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 01 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.6%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 05 98.2%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (43) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (75) $151
  • Intern/Summer Analyst (67) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
DrApeman's picture
DrApeman
98.9
6
Betsy Massar's picture
Betsy Massar
98.9
7
GameTheory's picture
GameTheory
98.9
8
dosk17's picture
dosk17
98.9
9
CompBanker's picture
CompBanker
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”